Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 3;26(1):1073274819887697. doi: 10.1177/1073274819887697

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Comparison of urinary sediment AMACR scores (A) and serum PSA (B) between patients with positive (n = 138) and negative (n = 154) biopsy in all patients. Comparison of urinary sediment AMACR scores (C) and serum PSA (D) between patients with positive (n = 37) and negative (n = 85) biopsy in “grey-zone PSA level” patients. Receiver operating characteristic-AUC analysis of AMACR score, serum PSA and duplex model in all prostate biopsy patients (E) and in the diagnosis of “PSA grey zone” biopsy patients (F). AMACR indicates α-methylacyl-CoA racemase; AUC, area under the curve; PSA, prostate-specific antigen.